ALLERGAN FDA Approval NDA 050586

NDA 050586

ALLERGAN

FDA Drug Application

Application #050586

Documents

Letter2006-01-19
Label2006-01-05
Letter2006-01-19
Label2006-01-05
Label2017-03-21
Letter2017-03-24
Label2018-06-11
Letter2018-06-14

Application Sponsors

NDA 050586ALLERGAN

Marketing Status

Prescription001

Application Products

001SUSPENSION/DROPS;OPHTHALMICEQ 0.3% BASE;1%1PRED-GGENTAMICIN SULFATE; PREDNISOLONE ACETATE

FDA Submissions

TYPE 4; Type 4 - New CombinationORIG1AP1988-06-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1988-07-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1988-07-29STANDARD
EFFICACY; EfficacySUPPL5AP1989-04-21
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1988-10-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1994-03-07STANDARD
LABELING; LabelingSUPPL13AP1991-12-30
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1995-08-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1996-12-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1997-10-01STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1998-05-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1999-04-26STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2000-10-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP2001-04-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL21AP2001-09-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL23AP2001-12-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL24AP2002-04-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL25AP2005-12-20STANDARD
LABELING; LabelingSUPPL26AP2005-12-20STANDARD
LABELING; LabelingSUPPL31AP2017-03-20STANDARD
LABELING; LabelingSUPPL32AP2018-06-07STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL4Null0
SUPPL7Null0
SUPPL10Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL23Null0
SUPPL24Null0
SUPPL25Null0
SUPPL31Null7
SUPPL32Null7

CDER Filings

ALLERGAN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50586
            [companyName] => ALLERGAN
            [docInserts] => ["",""]
            [products] => [{"drugName":"PRED-G","activeIngredients":"GENTAMICIN SULFATE; PREDNISOLONE ACETATE","strength":"EQ 0.3% BASE;1%","dosageForm":"SUSPENSION\/DROPS;OPHTHALMIC","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"06\/07\/2018","submission":"SUPPL-32","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/050586s032lbl.pdf\"}]","notes":""},{"actionDate":"03\/20\/2017","submission":"SUPPL-31","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/050586s031lbl.pdf\"}]","notes":""},{"actionDate":"12\/20\/2005","submission":"SUPPL-26","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/050586s025s026lbl.pdf\"}]","notes":""},{"actionDate":"12\/20\/2005","submission":"SUPPL-25","supplementCategories":"Manufacturing (CMC)-Packaging","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/050586s025s026lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"PRED-G","submission":"GENTAMICIN SULFATE; PREDNISOLONE ACETATE","actionType":"EQ 0.3% BASE;1%","submissionClassification":"SUSPENSION\/DROPS;OPHTHALMIC","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2018-06-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.